Literature DB >> 6737007

Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density.

C A Curcio, T Kemper.   

Abstract

Within the reticulate core of the brain the nucleus raphe dorsalis (NRD) is a major site of predilection for the neurofibrillary tangle (NFT) in dementia of the Alzheimer type (DAT) and, according to some studies, its primary brain stem site. In a quantitative study we have shown in six aged control brains an average of 5.2 NFT per histological section or 25.8 per mm3 and in seven age-matched brains with DAT a highly significant six-fold increase, respectively 35.3 NFT per histological section or 188.5 per mm3. There was no significant difference between the two groups in overall neuronal cell packing density. There was, however, a significant decrease in a subpopulation of neurons in DAT, a large polygonal neuron. Despite the prominence of the NRD as a target for NFT, the actual proportion of affected NRD cells was small, 0.35% in controls and 2.25% in DAT.

Entities:  

Mesh:

Year:  1984        PMID: 6737007     DOI: 10.1097/00005072-198407000-00001

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  27 in total

1.  NADPH-diaphorase-positive cell populations in the human amygdala and temporal cortex: neuroanatomy, peptidergic characteristics and aspects of aging and Alzheimer's disease.

Authors:  J W Unger; W Lange
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 2.  Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.

Authors:  Panos Theofilas; Sara Dunlop; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Projections from the medial septum and diagonal band of Broca to the dorsal and central superior raphe nuclei: a non-cholinergic pathway.

Authors:  P Kalén; L Wiklund
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

Review 4.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Molecular imaging of serotonin degeneration in mild cognitive impairment.

Authors:  Gwenn S Smith; Frederick S Barrett; Jin Hui Joo; Najlla Nassery; Alena Savonenko; Devin J Sodums; Christopher M Marano; Cynthia A Munro; Jason Brandt; Michael A Kraut; Yun Zhou; Dean F Wong; Clifford I Workman
Journal:  Neurobiol Dis       Date:  2017-05-13       Impact factor: 5.996

6.  Nucleus raphe dorsalis in parkinsonism-dementia complex of Guam.

Authors:  T Yamamoto; A Hirano
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

Review 7.  Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.

Authors:  Maria J Ramirez; Mitchell K P Lai; Rosa M Tordera; Paul T Francis
Journal:  Drugs       Date:  2014-05       Impact factor: 9.546

8.  Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly.

Authors:  S S Zhan; W Kamphorst; W E Van Nostrand; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer's Disease: Studies in an S100B Overexpressing Mouse Model.

Authors:  Lee A Shapiro; Lynn A Bialowas-McGoey; Patricia M Whitaker-Azmitia
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-22

10.  Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia.

Authors:  Y Ichimiya; H Arai; K Kosaka; R Iizuka
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.